BSE filing, NSE: SHILPAMED. Summary written from the filing by ALFA Finder's alert engine.
Shilpa Medicare Ltd: key numbers
- Share price
- ₹930.00
- Market cap
- ₹18,189 Cr
- Revenue (annual)
- ₹1,539 Cr
- Net profit (annual)
- ₹243.3 Cr
- P/E (TTM)
- 61.2×Sector 46.5×
- Promoter holding
- 40.13%+0.00% QoQ
- FII holding
- 12.11%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Shilpa Medicare Ltd
All →Shilpa Medicare Other Announcement
Shilpa Medicare Ltd has filed its quarterly shareholding pattern under Regulation 31(1)(b) for the quarter ended September 30, 2026.
Shilpa Medicare Other Announcement
Shilpa Medicare Ltd KMP Alpesh Maheshkumar Dalal sold 4,000 equity shares via market sale. The transaction was valued at Rs.0.42 Crore and executed on the NSE.
- Value
- ₹0.42 Cr
Shilpa Medicare Share Pledge
The company's promoters reported the release of encumbrance on 30,00,000 equity shares held by them. This reduction in pledged shares signals a change in promoter leverage.
Shilpa Medicare Other Announcement
Shilpa Medicare received a 'Crisil ESG 59' rating from CRISIL ESG Ratings for FY2026. This is a routine regulatory disclosure under Regulation 30 with no financial implications.
Shilpa Medicare Business Update
Shilpa Medicare reported a USFDA surveillance inspection at its Unit VII Analytical Services Division. The inspection resulted in one procedural observation with no material impact on operations.
Shilpa Medicare Regulatory Approval
Shilpa Medicare secured final CDSCO-SEC approval for OERIS™, a world-first extended-release ondansetron injection patented until 2039. Commercial launch in India is planned upon final marketing authorization.
Other business update announcements
All →Cybele Industries Business Update
Cybele Industries disclosed joint venture discussions with a third party, still at an initial stage. No agreement has been executed and no value is stated.
Dr. Reddy's Laboratories Business Update
Dr Reddy's says USFDA closed its PAI and GMP inspection at Srikakulam FTO-SEZ Process Unit-02 with VAI classification. The outcome is closed with no monetary penalty.
Vascon Engineers Business Update
Vascon Engineers awarded Neobridge Realty LLP a Rs.72 Crore shell and core work contract over 25 months. The contract is excluding GST and is described as ordinary course of business.
- Value
- ₹72.00 Cr
- Execution
- 25 months
Meesho Business Update
Meesho's Q2 FY27 shareholders' letter reports NMV up 23% YoY to ₹12,911 crore. Festive timing moved the Mega Blockbuster Sale into Q3.
Dhruv Consultancy Services Business Update
Dhruv Consultancy received an empanelment letter of intent for DPR work for Chhattisgarh government departments, valid for 36 months. No contract value or allotted work was disclosed.
- Execution
- 36 months
Peshwa Wheat Business Update
Peshwa Wheat reported unaudited half-year revenue of about Rs.129 Cr for September 2026, up from Rs.109 Cr. The company attributes growth to core wheat processing and by-product utilisation.
- Value
- ₹129.0 Cr